Algert Global’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-12,172
| Closed | -$364K | – | 1312 |
|
|
2025
Q3 | $364K | Sell |
12,172
-17,360
| -59% | -$579K | 0.01% | 966 |
|
|
2025
Q2 | $877K | Sell |
29,532
-5,590
| -16% | -$161K | 0.02% | 833 |
|
|
2025
Q1 | $1.07M | Buy |
35,122
+20,862
| +146% | +$702K | 0.03% | 753 |
|
|
2024
Q4 | $565K | Sell |
14,260
-3,560
| -20% | -$138K | 0.01% | 884 |
|
|
2024
Q3 | $691K | Buy |
17,820
+4,098
| +30% | +$166K | 0.02% | 834 |
|
|
2024
Q2 | $577K | Buy |
+13,722
| New | +$468K | 0.02% | 854 |
|
|
2022
Q2 | – | Sell |
-7,982
| Closed | -$362K | – | 1369 |
|
|
2022
Q1 | $362K | Sell |
7,982
-4,378
| -35% | -$192K | 0.02% | 918 |
|
|
2021
Q4 | $595K | Buy |
12,360
+1,200
| +11% | +$60.4K | 0.07% | 473 |
|
|
2021
Q3 | $620K | Buy |
11,160
+4,740
| +74% | +$263K | 0.08% | 448 |
|
|
2021
Q2 | $348K | Buy |
+6,420
| New | +$352K | 0.12% | 251 |
|
|
2018
Q3 | – | Sell |
-21,677
| Closed | -$1.2M | – | 383 |
|
|
2018
Q2 | $1.2M | Sell |
21,677
-2,378
| -10% | -$110K | 0.25% | 152 |
|
|
2018
Q1 | $915K | Buy |
+24,055
| New | +$745K | 0.18% | 193 |
|
|
2017
Q1 | – | Sell |
-48,196
| Closed | -$1.22M | – | 363 |
|
|
2016
Q4 | $1.22M | Sell |
48,196
-55,587
| -54% | -$1.46M | 0.35% | 115 |
|
|
2016
Q3 | $3.12M | Buy |
103,783
+26,565
| +34% | +$730K | 0.9% | 9 |
|
|
2016
Q2 | $1.81M | Buy |
77,218
+40,925
| +113% | +$897K | 0.74% | 19 |
|
|
2016
Q1 | $668K | Buy |
+36,293
| New | +$683K | 0.25% | 152 |
|
|
2014
Q1 | – | Sell |
-11,634
| Closed | -$284K | – | 370 |
|
|
2013
Q4 | $284K | Buy |
11,634
+2,187
| +23% | +$51.6K | 0.08% | 291 |
|
|
2013
Q3 | $225K | Buy |
+9,447
| New | +$202K | 0.06% | 301 |
|
Other funds holding SRDX
Algert Global's SRDX Position: Q4 2025 in Review
Algert Global sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 12,172 shares — an estimated $364K sold.
Algert Global first reported a position in SRDX in Q3 2013 and held it in 18 quarters. The position peaked at $3.12M in Q3 2016. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Algert Global reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Algert Global sold 12,172 Surmodics shares in Q4 2025, an estimated $364K.
- Algert Global first reported a position in Surmodics in Q3 2013 and held it in 18 quarters.
- Algert Global's Surmodics position peaked at $3.12M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.